Home

myocarditis cases per year chart

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization  | NEJM
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization | NEJM

Frontiers | Global, Regional, and National Burden of Myocarditis and  Cardiomyopathy, 1990–2017
Frontiers | Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017

Myocarditis following mRNA COVID-19 vaccination
Myocarditis following mRNA COVID-19 vaccination

Overview of Myocarditis Cases Caused by the COVID-19 Vaccine | DAIC
Overview of Myocarditis Cases Caused by the COVID-19 Vaccine | DAIC

COVID-19 Vaccine Myocarditis∗ : Cautious Reassurance in an Era of Dynamic  Uncertainty | Journal of the American College of Cardiology
COVID-19 Vaccine Myocarditis∗ : Cautious Reassurance in an Era of Dynamic Uncertainty | Journal of the American College of Cardiology

Here's all the data on myocarditis cases linked to COVID-19 vaccines | Ars  Technica
Here's all the data on myocarditis cases linked to COVID-19 vaccines | Ars Technica

Quantifying the risks versus benefits of the Pfizer COVID-19 vaccine in  Australia: a Bayesian network analysis | medRxiv
Quantifying the risks versus benefits of the Pfizer COVID-19 vaccine in Australia: a Bayesian network analysis | medRxiv

Trends in myocarditis incidence, complications and mortality in Sweden from  2000 to 2014 | Scientific Reports
Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014 | Scientific Reports

CDC says there's likely link between rare heart inflammation in young  people after Covid shot
CDC says there's likely link between rare heart inflammation in young people after Covid shot

Myocarditis mortality with and without COVID-19: insights from a national  registry | Clinical Research in Cardiology
Myocarditis mortality with and without COVID-19: insights from a national registry | Clinical Research in Cardiology

Myocarditis Hospitalizations in the COVID Era
Myocarditis Hospitalizations in the COVID Era

Update on myocarditis following mRNA COVID-19 vaccination
Update on myocarditis following mRNA COVID-19 vaccination

Long-Term Outcome of Fulminant Myocarditis as Compared with Acute  (Nonfulminant) Myocarditis | NEJM
Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis | NEJM

Abstract 11463: Epidemiological Trends and Outcomes of Acute Myocarditis in  the National Health Service of England | Circulation
Abstract 11463: Epidemiological Trends and Outcomes of Acute Myocarditis in the National Health Service of England | Circulation

Delayed-onset myocarditis following COVID-19 - The Lancet Respiratory  Medicine
Delayed-onset myocarditis following COVID-19 - The Lancet Respiratory Medicine

Reporting of immune checkpoint inhibitor-associated myocarditis - The Lancet
Reporting of immune checkpoint inhibitor-associated myocarditis - The Lancet

Evolution of acute myocarditis in a pediatric population: An MRI based  study - International Journal of Cardiology
Evolution of acute myocarditis in a pediatric population: An MRI based study - International Journal of Cardiology

Increased risk of myocarditis and pericarditis and reduced likelihood of  severe clinical outcomes associated with COVID-19 vaccination: a cohort  study in Lombardy, Italy | BMC Infectious Diseases | Full Text
Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy | BMC Infectious Diseases | Full Text

French study on cardiovascular disease incidence during COVID pandemic and  vaccination campaign
French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign

NEJM on X: "Among 2.5 million patients who received the BNT162b2 mRNA  vaccine in a large Israeli health care system, the incidence of myocarditis  at 42 days was 2.13 cases per 100,000
NEJM on X: "Among 2.5 million patients who received the BNT162b2 mRNA vaccine in a large Israeli health care system, the incidence of myocarditis at 42 days was 2.13 cases per 100,000

SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based  cohort study | The BMJ
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study | The BMJ

KoreaMed Synapse
KoreaMed Synapse

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM

Role of electrocardiograms in assessment of severity and analysis of the  characteristics of ST elevation in acute myocarditis: A two‑centre study
Role of electrocardiograms in assessment of severity and analysis of the characteristics of ST elevation in acute myocarditis: A two‑centre study

Association Between COVID-19 and Myocarditis Using Hospital-Based  Administrative Data — United States, March 2020–January 2021 | MMWR
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR

The Global Burden of Myocarditis: Part 1: A Systematic Literature Review  for the Global Burden of Diseases, Injuries, and Risk Factors 2010 Study -  ScienceDirect
The Global Burden of Myocarditis: Part 1: A Systematic Literature Review for the Global Burden of Diseases, Injuries, and Risk Factors 2010 Study - ScienceDirect

Frontiers | Global, Regional, and National Burden of Myocarditis and  Cardiomyopathy, 1990–2017
Frontiers | Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017